FOLH1 and prostate carcinoma: The integration of PET-PSMA imaging into prostate cancer management significantly impacts treatment decision-making by facilitating personalized approaches tailored to disease severity and aggressiveness, ultimately leading to more precise and effective management of prostate cancer across different clinical stages.